Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
44234 Results Found
FDA delays certification deadlines for Clozapine REMS Program
The Food and Drug Administration yesterday extended the prescriber and pharmacy certification deadlines for the new Clozapine Risk Evaluation and Mitigation Strategy Program, citing ongoing impleme
HHS announces $469 million in 2014 premium rebates under MLR
About 5.5 million Americans will receive premium rebates averaging $129 per family from health insurers who did not meet medical loss ratio requirements in 2014, according to a new
IHA president to join AHA as chief strategy/relationship officer, CEO of Health Forum
Maryjane Wurth will join the AHA on Jan.
NJ Council of Teaching Hospitals to transition key functions to NJHA
The New Jersey Hospital Association and the New Jersey Council of Teaching Hospitals have approved an agreement to transition the core functions of NJCTH into NJHA over the next year.
Hospitals brief Congress on benefits of 340B program, concerns with HRSA guidance
At an AHA-sponsored briefing today on Capitol Hill, hospital leaders shared with congressional staff the many benefits that the 340B Drug Pricing Program brings to vulnerable patients and urged Con
Congress urged to continue commitment to rural hospitals
In commemoration of National Rural Health Day, the AHA today expressed appreciation to members of the S
CMS seeks comments as it develops IRF, LTCH patient experience surveys
The Centers for Medicare & Medicaid Services seeks comments to inform its development of patient experience of care surveys for the
Half of Medicaid-eligible adults with behavioral health disorders live in non-expansion states
About 5.3 million uninsured adults with mental illness or substance use disorders are eligible for Medicaid coverage under the Affordable Care Act, but about half of them live in states that have n
FDA approves nasal-spray version of opioid overdose medication
The Food and Drug Administration today announced the first approved nasal-spray version of
Amid concerns of possible policy changes, hospitals brief Congress on 340B's benefits
At an AHA-sponsored briefing Nov.